中文 
别名:Mitogen-activated protein kinase kinase kinase 13, Leucine zipper-bearing kinase, Mixed lineage kinase, MLK, MAP3K13 (HGNC:6852)应用:WB
反应种属:Human
规格：50μl/100μl
| Description |
|---|
| Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B. |
| Specification | |
|---|---|
| Aliases | Mitogen-activated protein kinase kinase kinase 13, Leucine zipper-bearing kinase, Mixed lineage kinase, MLK, MAP3K13 (HGNC:6852) |
| Entrez GeneID | 9175 |
| Swissprot | O43283 |
| WB Predicted band size | 108.3kDa |
| Host/Isotype | Mouse IgM |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Purified His-tagged MAP3K13 protein fragment was used to produced this monoclonal antibody. |
| Formulation | Purified monoclonal antibody supplied in PBS with 0.05% sodium azide. This antibody is prepared by Euglobin precipitation followed by dialysis against PBS. |
| Application | |
|---|---|
| WB | 1/500 |
 |
Anti-MAP3K13 (LZK) Antibody (C-term) at 1:500 dilution + NCI-H460 whole cell lysate
Lysates/proteins at 20 µg per lane. Secondary Predicted band size : 110 kDa Blocking/Dilution buffer: 5% NFDM/TBST. |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
发表回复